Experienced in Myoclonic Epilepsy

Dr. Raphael Schiffmann

Neurology
Baylor Scott & White Health
Texas Neurology, P.A.
6080 N Central Expy, Ste 100, 
Dallas, TX 
Offers Telehealth
46 Years of Experience
Experienced in Myoclonic Epilepsy
Baylor Scott & White Health
Texas Neurology, P.A.
6080 N Central Expy, Ste 100, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Raphael Schiffmann is a Neurologist in Dallas, Texas. Dr. Schiffmann has been practicing medicine for over 46 years and is rated as an Experienced provider by MediFind in the treatment of Myoclonic Epilepsy. His top areas of expertise are Gaucher Disease Type 3, Fabry Disease, Gaucher Disease, and Leukodystrophy.

His clinical research consists of co-authoring 133 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Myoclonic Epilepsy.

Graduate Institution
University Of Liege, 1980.0
Residency
Pediatrics, Shaare Zedek Medical Center
Specialties
Neurology
Licenses
Neurology with Special Qualifications in Neurology in TX
Board Certifications
American Board Of Psychiatry And Neurology
Fellowships
Pediatric Neurology, Boston City Hospital
Pediatric Neurology, Tufts New England Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Scott and White Health
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Texas Neurology, P.A.
6080 N Central Expy, Ste 100, Dallas, TX 75206
Call: 972-449-0540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase 3 Open-Label Switch Over Study to Assess Safety, Efficacy & PK of Pegunigalsidase Alfa (PRX-102) 2mg/kg IV Every 4 Weeks for 52 Weeks in Fabry Disease Patients Currently Treated With Enzyme Replacement Therapy Fabrazyme® or Replagal™
Phase 3 Open-Label Switch Over Study to Assess Safety, Efficacy & PK of Pegunigalsidase Alfa (PRX-102) 2mg/kg IV Every 4 Weeks for 52 Weeks in Fabry Disease Patients Currently Treated With Enzyme Replacement Therapy Fabrazyme® or Replagal™
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drug: Pegunigalsidase Alfa
Study Phase: Phase 3
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Biological
Study Drugs: PRX-102 (Pegunigalsidase Alfa), Agalsidase Beta
Study Phase: Phase 3
An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12 Month Treatment With Migalastat in Pediatric Subjects (Aged 12 to <18 Years) With Fabry Disease and Amenable GLA Variants
An Open-label Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of 12 Month Treatment With Migalastat in Pediatric Subjects (Aged 12 to <18 Years) With Fabry Disease and Amenable GLA Variants
Enrollment Status: Completed
Publish Date: November 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open-Label Clinical Trial of Replagal® Enzyme Replacement Therapy in Children With Fabry Disease Who Are Naive to Enzyme Replacement Therapy
An Open-Label Clinical Trial of Replagal® Enzyme Replacement Therapy in Children With Fabry Disease Who Are Naive to Enzyme Replacement Therapy
Enrollment Status: Completed
Publish Date: June 09, 2021
Intervention Type: Biological
Study Phase: Phase 2
An Open-label Treatment Protocol to Evaluate the Safety of Replagal Treatment in Patients With Fabry Disease.
An Open-label Treatment Protocol to Evaluate the Safety of Replagal Treatment in Patients With Fabry Disease.
Enrollment Status: No_longer_available
Publish Date: May 24, 2021
Intervention Type: Biological
The Etiology, Pathogenesis, and Natural History of the Leukodystrophies
The Etiology, Pathogenesis, and Natural History of the Leukodystrophies
Enrollment Status: Completed
Publish Date: March 22, 2019
View 5 Less Clinical Trials

132 Total Publications

Expanded View of the Pathophysiology of Fabry Disease.
Expanded View of the Pathophysiology of Fabry Disease.
Journal: Nephron
Published: May 04, 2025
View All 132 Publications
Similar Doctors
Distinguished in Myoclonic Epilepsy
Dr. Charuta N. Joshi
Pediatric Neurology | Neurology
Distinguished in Myoclonic Epilepsy
Dr. Charuta N. Joshi
Pediatric Neurology | Neurology

Texas Scottish Rite Hospital For Children

2222 Welborn St, 
Dallas, TX 
 (3.5 miles away)
972-449-0540
Experience:
31+ years
Languages Spoken:
English
See accepted insurances

Charuta Joshi is a Pediatric Neurologist and a Neurologist in Dallas, Texas. Dr. Joshi has been practicing medicine for over 31 years and is rated as an Elite provider by MediFind in the treatment of Myoclonic Epilepsy. Her top areas of expertise are Epilepsy, Seizures, West Syndrome, Epilepsy in Children, and Deep Brain Stimulation.

Distinguished in Myoclonic Epilepsy
Dr. Roger S. Blair
Neurology
Distinguished in Myoclonic Epilepsy
Dr. Roger S. Blair
Neurology

UT Southwestern Monty And Tex Moncrief Medical Center At Fort Worth

600 South Main Street, 3rd Floor, Suite 3.200, 
Fort Worth, TX 
 (32.9 miles away)
817-882-2440
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Roger Blair is a Neurologist in Fort Worth, Texas. Dr. Blair is rated as a Distinguished provider by MediFind in the treatment of Myoclonic Epilepsy. His top areas of expertise are Epilepsy with Myoclonic-Atonic Seizures, West Syndrome, Myoclonic Epilepsy, and Epilepsy in Children. Dr. Blair is currently accepting new patients.

Distinguished in Myoclonic Epilepsy
Dr. Deepa Sirsi
Pediatric Neurology | Pediatrics | Neurology
Distinguished in Myoclonic Epilepsy
Dr. Deepa Sirsi
Pediatric Neurology | Pediatrics | Neurology
2350 Stemmons Freeway, 
Dallas, TX 
 (4.3 miles away)
214-456-2768
Languages Spoken:
English
See accepted insurances

Deepa Sirsi is a Pediatric Neurologist and a Pediatrics provider in Dallas, Texas. Dr. Sirsi is rated as a Distinguished provider by MediFind in the treatment of Myoclonic Epilepsy. Her top areas of expertise are Seizures, Epilepsy, Epilepsy in Children, and West Syndrome.

VIEW MORE MYOCLONIC EPILEPSY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schiffmann's expertise for a condition
ConditionClose
  • Elite
  • Fabry Disease
    Dr. Schiffmann is
    Elite
    . Learn about Fabry Disease.
    See more Fabry Disease experts
  • Gaucher Disease
    Dr. Schiffmann is
    Elite
    . Learn about Gaucher Disease.
    See more Gaucher Disease experts
  • Gaucher Disease Type 3
    Dr. Schiffmann is
    Elite
    . Learn about Gaucher Disease Type 3.
    See more Gaucher Disease Type 3 experts
  • Distinguished
  • Adult Polyglucosan Body Disease
    Dr. Schiffmann is
    Distinguished
    . Learn about Adult Polyglucosan Body Disease.
    See more Adult Polyglucosan Body Disease experts
  • CACH Syndrome
    Dr. Schiffmann is
    Distinguished
    . Learn about CACH Syndrome.
    See more CACH Syndrome experts
  • Farber Lipogranulomatosis
    Dr. Schiffmann is
    Distinguished
    . Learn about Farber Lipogranulomatosis.
    See more Farber Lipogranulomatosis experts
  • Leukodystrophy
    Dr. Schiffmann is
    Distinguished
    . Learn about Leukodystrophy.
    See more Leukodystrophy experts
  • Megalencephalic Leukoencephalopathy with Subcortical Cysts
    Dr. Schiffmann is
    Distinguished
    . Learn about Megalencephalic Leukoencephalopathy with Subcortical Cysts.
    See more Megalencephalic Leukoencephalopathy with Subcortical Cysts experts
  • Pol 3-Related Leukodystrophy
    Dr. Schiffmann is
    Distinguished
    . Learn about Pol 3-Related Leukodystrophy.
    See more Pol 3-Related Leukodystrophy experts
  • Advanced
  • Metachromatic Leukodystrophy
    Dr. Schiffmann is
    Advanced
    . Learn about Metachromatic Leukodystrophy.
    See more Metachromatic Leukodystrophy experts
  • Experienced
  • Acid Sphingomyelinase Deficiency (ASMD)
    Dr. Schiffmann is
    Experienced
    . Learn about Acid Sphingomyelinase Deficiency (ASMD).
    See more Acid Sphingomyelinase Deficiency (ASMD) experts
  • Alexander Disease
    Dr. Schiffmann is
    Experienced
    . Learn about Alexander Disease.
    See more Alexander Disease experts
  • Alternating Hemiplegia of Childhood
    Dr. Schiffmann is
    Experienced
    . Learn about Alternating Hemiplegia of Childhood.
    See more Alternating Hemiplegia of Childhood experts
  • Andersen Disease
    Dr. Schiffmann is
    Experienced
    . Learn about Andersen Disease.
    See more Andersen Disease experts
  • Brown Syndrome
    Dr. Schiffmann is
    Experienced
    . Learn about Brown Syndrome.
    See more Brown Syndrome experts
  • Canavan Disease
    Dr. Schiffmann is
    Experienced
    . Learn about Canavan Disease.
    See more Canavan Disease experts
View All 40 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Close
      0 / 1000

      Please provide us with the below insurance information:

              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.